Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMR vs GSK✓SelectedUSD · GSKSMR vs GSK performance historyLatest closeAs of-2.56%11/19
Stock and ETF performance explorer

SMR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+48.8%
GSK return
+53.5%
Excess return
-4.7%
Maximum drawdown
-92.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.6%-1.6%-1.0%-2.6%
7D-21.0%-4.7%-16.2%-21.1%
30D-31.7%-4.7%-27.0%-31.7%
3M-59.0%-8.8%-50.2%-59.0%
6M-62.1%-4.6%-57.5%-62.1%
YTD-73.1%+1.0%-74.1%-72.9%
1Y-82.0%+6.9%-88.8%-81.9%
All+48.8%+53.5%-4.7%+48.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling